Welcome to our dedicated page for Omega Healthcare SEC filings (Ticker: OHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Omega Healthcare Investors, Inc. (NYSE: OHI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Omega is a real estate investment trust focused on long-term healthcare real estate, and its filings offer detailed insight into how it finances and manages skilled nursing, assisted living and other healthcare-related properties in the United States and the United Kingdom.
Investors can review current reports on Form 8-K, where Omega reports material events such as new senior unsecured credit facilities, amendments to term loans, public offerings and redemptions of senior notes, and the establishment of at-the-market equity offering programs. These filings also describe key terms of debt instruments, including interest rates, maturities, covenants and guarantees, as well as amendments to executive employment agreements and other corporate actions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q, when available, provide broader context on Omega’s portfolio of long-term healthcare facilities, its use of triple-net leases, exposure to U.S. and U.K. markets and risk factors related to operator performance, reimbursement, regulation and capital markets. Proxy materials and other filings can include information on governance and executive compensation.
On Stock Titan, these documents are complemented by AI-powered summaries that highlight the main points from lengthy filings, helping users quickly understand changes in Omega’s capital structure, borrowing arrangements, equity issuance plans and relationships with healthcare operators. The filings page also surfaces insider-related disclosures, where applicable, so users can track material updates in one place while retaining the ability to read the full SEC documents for complete detail.
Omega Healthcare Investors’ chief financial officer reports equity award activity and a small stock disposition. On December 30, 2025, the CFO reported a disposition of 3,850 shares of common stock coded as a transaction type "G" at a stated price of $0, leaving 178,426 shares of common stock beneficially owned directly.
The filing also details the vesting and conversion of Profits Interest Units in OHI Healthcare Properties Limited Partnership into OP Units, and related movements between OP Units and common stock, all at a stated exercise or conversion price of $0. These interests are tied to performance-based and time-based vesting conditions, including measures such as Absolute and Relative Total Shareholder Return for the 2022–2024 period and ongoing employment requirements.
Omega Healthcare Investors insider reporting shows activity by its Chief Executive Officer and director involving operating partnership units and performance-based awards. On December 30, 2025, the reporting person redeemed 200,000 OP Units in OHI Healthcare Properties Limited Partnership, which are exchangeable for cash equal to the average closing price of Omega’s common stock over a 10-day period, noted here as $45.25 per share equivalent. The filing also details multiple awards of Profits Interest Units that can vest into OP Units and, in some cases, be settled in common stock, with several transactions reported at an exercise price of $0.
The report states that a portion of the OP Unit redemption, tied to 20,000 underlying shares, was matchable under Section 16(b) against a prior purchase on November 5, 2025, and the insider paid $22,144.00 to the company as the full profit on that short-swing transaction.
Cohen & Steers filed a Schedule 13G reporting a passive stake in Omega Healthcare Investors, Inc. (OHI). The filing discloses beneficial ownership of 17,466,234 shares of common stock, representing 5.92% of the class as of the event date 09/30/2025. Cohen & Steers reports sole voting power over 13,494,467 shares and sole dispositive power over 17,466,234 shares.
Subsidiary-level holdings include Cohen & Steers Capital Management, Inc. with 17,268,702 shares (5.85%), Cohen & Steers UK Ltd. with 179,357 shares (0.06%), and Cohen & Steers Ireland Ltd. with 18,175 shares (0.01%). The filer certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
State Street Corporation filed a Schedule 13G reporting beneficial ownership of Omega Healthcare Investors, Inc. (OHI) common stock. It reports 14,625,474 shares beneficially owned, representing 5% of the class, with shared voting power over 12,034,325 shares and shared dispositive power over 14,625,474 shares; sole voting and dispositive power are each 0.
The filing is dated as of September 30, 2025, and includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Listed affiliated investment adviser entities include multiple State Street Global Advisors units.
Omega Healthcare Investors (OHI)
Omega Healthcare Investors (OHI) reported an insider purchase by its Chief Executive Officer and director. On 11/05/2025, the reporting person bought 20,000 shares of common stock (transaction code P) at a weighted average price of $43.1428, with individual trade prices ranging from $43.05 to $43.25.
Following the transaction, beneficial ownership consists of 20,000 shares held indirectly through a family trust and 4,100 shares held directly.
Omega Healthcare Investors, Inc. established a new at‑the‑market equity offering program, permitting sales of common stock—directly and via forward sales—for an aggregate gross sales price of $2,000,000,000, and terminated its prior ATM dated September 6, 2024. Sales may occur from time to time on the NYSE, through negotiated transactions, or otherwise, with no obligation to sell and with the ability to suspend offers.
The arrangement includes forward sale agreements under which a forward purchaser may borrow and sell shares through a forward seller. Omega expects to physically settle forwards and receive proceeds by delivering shares, but it may elect cash or net share settlement, which would result in no proceeds and potential cash or share obligations. Sales agents may receive up to 2.0% of the gross sales price; forward sellers earn commissions up to 2.0% via reduced initial forward prices. The securities are offered under an automatic shelf on Form S‑3 with a prospectus supplement dated November 3, 2025.
Omega Healthcare Investors (OHI) reported stronger Q3 results. Total revenue rose to $311.6 million from $276.0 million a year ago, and diluted EPS increased to $0.59 from $0.42. Net income was $185.0 million versus $114.9 million. For the first nine months, revenue reached $870.9 million compared with $772.1 million last year, and net income was $437.5 million.
Omega was active on both acquisitions and dispositions. Year‑to‑date, it acquired 66 facilities for $637.9 million across the U.S., U.K. and Jersey, generally at initial cash yields around 10%. It sold 45 facilities for $264.1 million, recognizing $61.2 million of net gains. The company recorded $16.6 million of impairments year‑to‑date. In February, the $201.8 million Inspir Embassy Row ALF was placed into service, contributing $3.3 million of Q3 rent. Operating cash flow for the first nine months was $647.9 million, ending Q3 with $737.2 million in cash. Common shares outstanding were 295.5 million, and dividends declared were $0.67 per share in Q3 (year‑to‑date $2.01).
Omega Healthcare Investors, Inc. (OHI) furnished a press release announcing its financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 to a Form 8-K and is incorporated by reference.
The information was provided under Item 2.02 and, along with Exhibit 99.1, is furnished and not deemed “filed” under Section 18 of the Exchange Act. Additional exhibits include Exhibit 104 (Cover Page Interactive Data File).
Omega Healthcare Investors (OHI) redeemed its 5.250% Senior Notes due 2026 in full. On October 15, 2025, the company retired all $600 million aggregate principal amount of the notes. It deposited $607,875,000 with the trustee to cover the redemption price, which equaled 100% of principal plus accrued and unpaid interest to, but not including, the redemption date.
With the redemption completed, the related obligations of Omega and its subsidiary guarantors were terminated, and the governing indenture was discharged. Certain customary provisions for trustee compensation, indemnification, and application of trust funds continue to apply.
FAQ
What is the current stock price of Omega Healthcare (OHI)?
What is the market cap of Omega Healthcare (OHI)?
